Long COVID “Brain Fog” Trial: Goal-Oriented Rehab Helped Goals—Fatigue Didn’t
A July 1, 2026 randomized trial (CICERO) tested goal-oriented cognitive rehabilitation for long COVID “brain fog.” It improved participants’ personalized functional goal attainment at 3 months and maintained the advantage at 6 months. But the trial did not show clear improvement in fatigue/post-exertional malaise (PEM) or several other symptom domains.
“Brain fog” after COVID can make everyday tasks feel harder—like remembering steps, focusing at work, or following through on routines. A key question for long COVID patients is whether cognitive rehabilitation can help, and whether any gains extend to the symptoms that often travel with brain fog, like fatigue and PEM.
A new randomized clinical trial (CICERO), published July 1, 2026 in JAMA Network Open, offers useful—but specific—answers.
What the CICERO trial tested
CICERO enrolled adults with prior COVID-19 infection who had persistent, objective cognitive impairment consistent with long COVID. The trial compared:
- Goal-oriented cognitive rehabilitation: individualized rehab built around a small set of personally meaningful functional goals (for example, improving the ability to complete real-world tasks). Participants received weekly, therapist-led sessions over a structured program.
- Treatment as usual (TAU): care that varied by participant and setting (with access to standard services such as specialist memory clinics and symptom management that differed person to person).
The study was conducted in the United Kingdom (NHS settings). While the intervention was described as feasible for remote delivery, it is important for U.S. readers to remember that service access and care pathways may differ.
Main results: goal attainment improved—and persisted
The trial’s primary outcome was patient-reported goal attainment at 3 months, and the researchers also assessed outcomes at 6 months.
- At 3 months: the goal-oriented cognitive rehabilitation group had significantly higher goal attainment than treatment as usual.
- At 6 months: the advantage persisted, though the effect appeared smaller than at 3 months.
In practical terms, this means the program helped more participants make progress toward concrete, everyday outcomes they said mattered to them.
What improved most vs. what didn’t
It’s tempting to treat “brain fog” as one symptom bundle. CICERO suggests the response to rehab may be more symptom-specific.
Improved: functional goal outcomes (and some cognitive task measures)
The clearest benefit was on functional outcomes tied to individualized goals. The authors also reported improvements on some cognitive performance measures, including measures related to higher-level thinking/executive functioning.
Not clearly improved: fatigue/PEM and several other symptom domains
Despite being designed for cognitive impairment, the trial did not show clear, statistically significant improvements in several commonly overlapping long COVID symptom areas, including:
- Fatigue
- Post-exertional malaise (PEM)
- Other symptom domains assessed in the trial (such as mood and sleep-related outcomes)
Safety: no trial-related adverse events reported
The trial reported no trial-related adverse events.
How this could fit long COVID care in the U.S.
U.S. guidance for long COVID emphasizes care plans that are tailored to the patient’s goals and aimed at improving function and quality of life. A goal-oriented approach aligns with that framework.
At the same time, CICERO’s pattern matters: if your hardest symptom is fatigue or PEM, this trial’s results suggest that “brain fog” cognitive rehab may not automatically resolve those issues. Many people will likely need a plan that addresses:
- cognitive/functional goals (what you want to be able to do), and
- PEM-aware pacing (how you’ll manage symptoms after exertion, since PEM can involve delayed worsening after activity).
Practical next steps for readers (without over-interpreting one study)
- Ask for a function-based assessment.
Don’t stop at “memory testing.” Aim for an evaluation that connects symptoms to everyday activities and identifies specific, measurable goals. - Define what success looks like for you.
Pick a few concrete outcomes (work tasks, managing appointments, returning to a hobby, household routines) and track whether you can do them more consistently. - Bring fatigue/PEM into the plan early.
If exertion triggers delayed symptom worsening, ask how pacing and activity planning will be handled alongside cognitive rehab goals. - Be cautious with “brain training” as a substitute.
Home apps may help some people, but CICERO tested a structured, goal-oriented rehab program—not a single consumer product. - Use symptom safety common sense.
If symptoms are rapidly worsening or involve urgent concerns (for example, new neurological deficits), seek timely medical evaluation.
Key limits to know before expecting the same results
- Location and services: the trial was conducted in the UK, where referral pathways and rehab access can differ from the U.S.
- Blinding: the study was single-blind and not fully double-blinded—common in behavioral interventions, but still a reason to interpret symptom outcomes conservatively.
- Who participated: the participant group may not represent all long COVID patients (including differences in demographics and educational background).
The bottom line
CICERO provides randomized-trial evidence that goal-oriented cognitive rehabilitation can improve functional goal attainment for people with long COVID–related cognitive impairment—and that benefit can last beyond 3 months. But it also suggests that fatigue/PEM may require a different or additional treatment approach.
For U.S. readers, a reasonable next step is to pursue assessment and rehab planning that is explicitly tied to real-world goals—while also addressing PEM-aware pacing when relevant.
Key sources
- CDC: Long COVID Clinical Guidance (HCP)
- MedlinePlus: Long COVID / Post-COVID Conditions
- AAPM&R: Long COVID / PASC Clinical Guidance
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
